Business Alliance on the New Radiopharmaceutical 'Metastron Injectable' (Japan)
This article was originally published in PharmAsia News
Nippon Kayaku Co. is partnering with Nihon Medi-Physics. The two companies are teaming up to focus on the Japanese distribution of Metastron Injectable. A radiopharmaceutical developed by GE Healthcare, the Metastron Injectable is designed to treat pain associated with metastasized bone cancer. Under the terms of their partnership, Nippon will focus on how to best market Metastron Injectable to healthcare facilities. Nihon will then concentrate finding best practices for the injection's import and distribution as well as educating medical practitioners on its safe and effective use. (Click here for more
You may also be interested in...
Chobani introduces Chobani Probiotic, its first functional probiotics beverage to support digestive and immune health; Danone North America extends its Danimals children’s yogurt line with products to support immune system; and Plexus Worldwide and Sofar Americas roll out children’s probiotics.
Report quantifies social media posts describing adverse events involving the Essure contraceptive device, which was pulled from the market amid safety concerns.
Deal Snapshot: The China/US CAR-T firm will be bought out by its management team and institutional investors in a deal structured as a merger into a new company.